Trial Profile
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg ODT for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Rizatriptan (Primary)
- Indications Migraine
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 16 Mar 2012 This trial is recruiting in Spain and France.
- 26 Jan 2011 The secondary endpoints Sustained Pain Relief (SPR), Pain Freedom (PF), Normal Rating of Functional Disability (NRFD), and Treatment Satisfaction (TS) were added, according to ClinicalTrials.gov .
- 27 Jun 2010 Results were reported at the 52nd Annual Scientific Meeting of the American Headache Society.